下一个

自动播放

PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat

10 意见 • 07/08/23
分享
嵌入
administrator
administrator
订户
0

UCLA oncologist Gottfried Konecny, MD, gives an overview of the PARP inhibitors olaparib, niraparib, and rucaparib, which have been approved for the treatment of ovarian cancers and how to proactively plan for and manage treatment-related toxicities. #UCLAMDChat

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放